Citiimaging Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
- Paid Up Capital ₹ 1.16 Cr
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Revenue Growth -45.54%
- Profit Growth -68.61%
- Ebitda -64.60%
- Net Worth 1.05%
- Total Assets 0.25%
About Citiimaging Diagnostics
Citiimaging Diagnostics Private Limited (CDPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 October 2015 (Nine years and four months 5 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.16 Cr.
The company currently has active open charges totaling ₹5.00 M.
Shashikant Thorat, Sandip Dole, Rupesh Kamathe, and Nine other members serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900PN2015PTC156734
-
Company No.
156734
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Oct 2015
-
Date of AGM
28 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Citiimaging Diagnostics?
Board Members (12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupesh Kamathe
|
Director | 06-Oct-2015 | Current |
|
Shashikant Thorat
|
Director | 06-Oct-2015 | Current |
|
Sandip Dole
|
Director | 06-Oct-2015 | Current |
|
Pradeep Joshi
|
Director | 06-Oct-2015 | Current |
|
Manohar Kawade
|
Director | 06-Oct-2015 | Current |
|
Shashikant Gulve
|
Director | 06-Oct-2015 | Current |
Financial Performance of Citiimaging Diagnostics.
Citiimaging Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 45.54% decrease. The company also saw a substantial fall in profitability, with a 68.61% decrease in profit. The company's net worth moved up by a moderate rise of 1.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Citiimaging Diagnostics?
In 2023, Citiimaging Diagnostics had a promoter holding of 15.52% and a public holding of 84.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kurion Health Private LimitedRupesh Kamathe is a mutual person
Charges (Loans)
₹0.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Mar 2016 | Bank Of India | ₹5.00 M | Open |
How Many Employees Work at Citiimaging Diagnostics?
Unlock and access historical data on people associated with Citiimaging Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Citiimaging Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citiimaging Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.